📢 Generic Entresto is now available at Cost Plus Drugs ❗️
Sacubitril/Valsartan is now on https://t.co/HixgZoTxWB. A big step forward for those managing chronic heart failure.
Available in:
💊 24mg/26mg 30 tablets - $33.75 - https://t.co/TN4CzXDlyN
💊 49mg/51mg 30 tablets - $33.75 - https://t.co/PFy11OjWY2
💊 97mg/103mg 30 tablets - $33.75 - https://t.co/DXgs7wWMA1
➡️ No membership fees. No insurance needed. Just transparent pricing! Sign up today at https://t.co/Xk3eIxk7KS
⭐️ Thank you to Ascend Laboratories for making this possible!
We are excited to feature another great PGY2 CE Spotlight! This week Dr. Lauren Inglis, @lauren_inglis_ from the Brigham and Women's Hospital, @BrighamPharmacy.
Dr. Inglis is here to discuss Approaches to Manage Vasoplegia in Post-Op CT Surgery!
#CardioED#CTSurgery
Late-breaker at #ACC2025: Dr. Joo-Yong Hahn presented the SMART-CHOICE 3 trial, showing superior efficacy and comparable safety of clopidogrel as long-term maintenance monotherapy in high-risk pts compared to aspirin. Slides here: https://t.co/XLZy7c4e6j
Of >105,000 participants with 30-year follow-up, only 9.3% achieved healthy aging (age 70, w/o any chronic diseases). Their diet was significantly associated with this outcome🧵 @NatureMedicine
First @ACCinTouch Concise Clinical Guidance (CCG) streamlines processes for implementing best practices in patient care. This CCG focuses on evaluating & managing #cardiogenicshock, answering 🔑 clinical questions & providing actionable guidance. https://t.co/ZOKfMIeuji #JACC
Does the timing of your coffee matter? Read more about the impact of coffee timing on health in #EHJ.
https://t.co/eQv8twOd6o
#coffee #mortality#cardiotwitter @ESC_Journals@escardio
Extended-dose DOAC vs full-dose DOAC #Renove RCT #ASH24 Late breaking abstract. Officially, reduced dose was not non-inferior, but recurrent #VTE rates were low and there is a substantial reduction in major and non-major bleeding. Congrats to @FCouturaud & @INNOVTE1
Bumetanide nasal spray safe, has equivalent pharmacodynamic efficacy (urine/sodium output) compared to IV and PO bumetanide administration. View slides here: https://t.co/haNDuPvRn9
🧵/ Late breaking science results from #AHA24 will be posted to this thread at the time of presentation:
BPROAD
SUMMIT
NTLA-2001
VANISH2
OPTION
BRAIN AF
PHARM-HF A&F
AI-ECHO
GLORIOUS
CLEAR SYNERGY
MHYH
ALPACAR
⬇️
(bookmark this post)
Great point here by @DHpharmd! Cardiology is very sensitized to “statin aversion” similar to ID and “penicillin allergy”. Can be problematic when trying to use the best evidence-based therapies. #idweek2024
1/ Published today, the Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery
📷: Stepwise Approach to Perioperative Cardiac Assessment.
Mechanistic Differences between Torsemide and Furosemide
Prospective data debunks classic teachings
🔵No meaningful PK/PD advantages for T
🔵Kidney bioavailability less w T
🔵Ratio T:F was 4:1 (not 2:1!)
🔵T w ⬆️neurohormonal activ & kidney dysfunction
https://t.co/PwoZ2tcpqY
Reversal of direct oral anticoagulants: Guidance from the SSC of the ISTH-- now online and In Press: https://t.co/URQrtl4f3q Kudos to our authors @JRand083, @connors_md, @LanaCastellucci, @MarcSamama, @DebSiegal, Dr ELindhoff, @biancaRoccaTwt, Prof J Weitz @isth, @JTHjournal